Find the right fit for you - faster
Get tailored insights about working at FOXO Technologies in one quick step.
FOXO Technologies Snapshot
2 OfficesLocations
FOXO Technologies, Inc. (“FOXO,” “Company,” “We,” or “Our”) discovers, creates, and commercializes epigenetic technology with advanced analytical tools and artificial intelligence (AI). We see broad application for our technology in Research, Longevity Insurance, and other market verticals, such as the pharmaceutical industry.
Our opportunity arises from the development of two independent technologies:
· DNA sequencing platforms that produce troves of genomic data; and
· AI and bioinformatic tools that analyze genomic and phenotypic data.
We believe the convergence of these two technologies offers a new epoch in scientific understanding of biological systems. Our goal is to service vertical markets with best-in-class technology tools, products and services that extend human lifespan. The goals and strategies we use to commercialize and deploy our technology range in scope, depth and breadth based upon our internal expertise, research findings, ability to partner, and capital resources.
Our opportunity arises from the development of two independent technologies:
· DNA sequencing platforms that produce troves of genomic data; and
· AI and bioinformatic tools that analyze genomic and phenotypic data.
We believe the convergence of these two technologies offers a new epoch in scientific understanding of biological systems. Our goal is to service vertical markets with best-in-class technology tools, products and services that extend human lifespan. The goals and strategies we use to commercialize and deploy our technology range in scope, depth and breadth based upon our internal expertise, research findings, ability to partner, and capital resources.
FOXO.Life is developing and launching its own unique life insurance product offering that incorporates individual molecular health and wellness insights for insured customers as a key benefit of its insurance product.
FOXO.Life believes this low-cost, subscription based model, is an excellent entry point for its health and wellness engagement model to drive renewal persistence, and ultimately transitioning into new products which are permanent in nature or otherwise developed.
FOXO.Life is a wholly owned subsidiary of FOXO Technologies (collectively “FOXO”) whose mission is to discover, develop, and implement a next-generation underwriting protocol based upon molecular biomarkers of health and wellness for the global longevity insurance industry.
FOXO.Life believes this low-cost, subscription based model, is an excellent entry point for its health and wellness engagement model to drive renewal persistence, and ultimately transitioning into new products which are permanent in nature or otherwise developed.
FOXO.Life is a wholly owned subsidiary of FOXO Technologies (collectively “FOXO”) whose mission is to discover, develop, and implement a next-generation underwriting protocol based upon molecular biomarkers of health and wellness for the global longevity insurance industry.
